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ABSTRACT 
 
 Even though the Association of Sleep Disorders Center was founded in 1976, sleep 
medicine wasn’t considered a specialty until 1996. The United States population has 
undergone a 20% decrease in sleep time over the past century, with a concurrent 
increase in reported sleep disorders. Sleep disorders are similar to the “silent killer” 
heart disease in that they frequently go undiagnosed. While personal health can be 
affected by sleep disorders, there is also a risk to third parties. Big trucks are responsible 
for 4,000 fatalities yearly, and 28% of commercial driver’s license (CDL) drivers have 
diagnosed sleep apnea.  A government passed bill HR3095 regulates physical exams 
required by CDL drivers. A licensed CDL driver now has to be seen by a medical 
examiner registered by the National Registry of Certified Medical Examiners to be 
eligible to drive once diagnosed with a sleep disorder. Several treatments are offered to 
alleviate the symptoms of sleep disorders.  The standard form of treatment requires 
patients to wear devices that often result in low compliance.  However, it is unclear what 
types of treatments patients try, and whether they eventually find a treatment that works 
to alleviate their symptoms. 
 This study was performed on 86 subjects to obtain a census of what treatments 
people who had been diagnosed with sleep disorders used to alleviate their symptoms. 
There are no current cures for sleep disorders but the symptoms can be managed. This 
survey assesses patient knowledge and where they acquired their information about 
sleep disorders and treatment, which treatments were used, what symptoms were 
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experienced, and quality of life issues. The majority of subjects acquired their 
information about sleep disorders from their dentists, sleep physician, family doctor, 
family/friends and the internet (94%). Over 76% of the subjects stated that they had 
sleep disordered breathing symptoms for 6 years or more. There were several modalities 
of treatments used; nonsurgical, surgical and pharmacological. The two preferred 
treatments of choice were continuous positive airway pressure (CPAP) machines and 
adjustable oral appliances (aOA). Subjects used aOA (80.2%) more often than CPAP 
(11.6%). Mann Whitney U-tests showed significantly fewer traveling difficulties and 
less interference with their quality of life with aOA than CPAP use.  There was 
significant improvement after treatment in snoring, fatigue, and feeling refreshed in the 
morning regardless of treatment modality.   
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NOMENCLATURE 
 
AASM= American Academy of Sleep Medicine 
AADSM= American Academy of Dental Sleep Medicine 
AF=  Atrial Fibrillation 
AHI=  Apnea Hypopnea Index 
aOA= Adjustable Oral Appliance 
ASDC=  Association of Sleep Disorders Center 
ANC=  Adjusted Neck Circumference 
BiPAP=  Bi-level Positive Airway Pressure 
BMI=  Body Mass Index 
CDL=  Commercial Driver’s License 
CEU=  Continuing Education Credits 
CompSAS=  Mixed /Complex Sleep Apnea 
CPAP=  Continuous Positive Airway Pressure 
CSA=  Central Sleep Apnea 
DOT=  Department of Transportation 
FMSCA=  Federal Motor Carrier Safety Administration 
HST=  Home Sleep Test 
ICSD=  International Classification of Sleep Disorders 
MAD=  Mandibular Advancement Devices 
NRCME= National Registry of Certified Medical Examiners 
OSA=  Obstructive Sleep Apnea 
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PSG=  Polysomnogram 
RDI=  Respiratory Disturbance Index 
RERA=  Respiratory Effort Related Arousals 
SAQLI (QOL)= Sleep Apnea Quality of Life Index or Quality Of Life 
SDB=  Sleep Disordered Breathing 
UARS=  Upper Airway Resistance Syndrome 
UPPP=  Uvulopalatopharyngoplasty 
UTHSC=  University of Tennessee Health Science Center College of Dentistry 
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CHAPTER I 
 INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Background and Significance 
 The Association of Sleep Disorders Center (ASDC) was founded in 1976, but the 
American Medical Association did not recognize sleep medicine as a specialty until 
1996 [1]. Sleep disorders have been recorded as far back as ancient Egypt.  Therefore, 
sleep disorders are not a new condition; the medical community has recognized the need 
for this condition to be described and treated [1].  
The 1993 report of the National Commission on Sleep Disorders research has 
estimated that the total sleep time for the United States population has decreased by 20% 
over the past century [2, 3]. The first clinically significant report of symptoms of chronic 
daytime sleepiness was made in 1965[2, 4]. As part of its effort to improve the nation’s 
health, the United States government has developed the Dietary Guidelines for 
Americans and the Physical Activity Guidelines for Americans. The American Academy 
of Sleep Medicine (AASM) and the Sleep Research Society promote the daily guidelines 
developed by the government for healthy living [3]. For example the Dietary Guidelines 
for Americans in conjunction with the American Heart Association suggest a daily 
intake of sodium of 1500mg or less for African- Americans and those with hypertension, 
diabetes, and chronic kidney disease [5]. The Physical Activity Guidelines for 
Americans suggest an adult should participate in at least 150 minutes of moderate-
intensity aerobic activity, 75 minutes of vigorous-intensity aerobic activity, or a 
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combination weekly [6]. To have the energy to accomplish the suggested exercise 
Americans have to get enough sleep.  
 The AASM and the Sleep Research Society have developed a document “Sleep: a 
health imperative” to educate the nation on the importance of adequate sleep [3].  The 
Institute of Medicine estimates that 50 to 70 million adult Americans have some type of 
chronic sleep disorder that contributes to poor health [3]. Broad societal changes; 
including longer work hours, which leads to longer commutes and increasing 
dependency on technology has also contributed to growing sleeping deficiency[3]. Over 
the past 20 years the percentage of men and women sleeping less than 6 hours per night 
has increased significantly [3].Therefore,  researchers have come to realize that sleep-
disordered breathing is a primary contributor to the decrease in sleep time. While the 
ability to recognize, treat, and identify such disorders has improved, there is still a need 
for further advances.  
 
 
1.2 Classifications of Sleep Disorders  
 In order to recognize sleep disorders the basics of sleep disorders should be 
understood. There are three categories of sleep-disordered breathing (SDB), snoring, 
upper airway resistance syndrome and sleep apnea syndrome. There are 3 types of sleep 
apnea: central sleep apnea (CSA), mixed/complex sleep apnea (CompSAS) and 
Obstructive Sleep Apnea (OSA) [7]. Central sleep apnea is the cessation of air flow 
without respiratory effort[8](Malhotra & Owens, 2010)[8]. In CSA the brain fails to tell 
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the respiratory muscles to facilitate breathing. CSA is usually associated with serious 
illness and damage to the lower brainstem. Mixed or complex apnea (CompSAS) is a 
combination of central sleep apnea and obstructive sleep apnea. CompSAS describes 
patients with obstructive sleep apnea that is complicated by central sleep apnea 
tendencies[8].These tendencies manifest themselves as Cheyne-Stokes breathing 
(increased respiratory effort) when the patient is on a CPAP machine[8]. The etiology 
for this syndrome is unclear, but it is thought to be predominantly a derangement of 
respiratory control coexisting with upper airway obstruction [7].Obstructive sleep apnea 
is the most common form of sleep apnea. OSA is a condition where there is a cessation 
of breathing for 10 or more seconds (apnea) and/or the inability to take a full effective 
breath (hypopnea) while sleeping[9].  Apnea and hypopnea have been shown to be 
caused by various types of upper airway obstructions.  
 The accepted theory has been that sleep apnea primarily affects obese middle aged 
men over 50.  It is now realized that women and younger people are also susceptible to 
sleep apnea and sleep disorders. More often than not, the disease manifests itself in 
women as upper airway resistance syndrome. The latest statistics report that sleep apnea 
is a major public health problem that affects 9% of women and 24%  of men between the 
ages of 30 and 60[10]. 
 Upper airway resistance syndrome (UARS) is a sleep disorder characterized by 
upper airway resistance due to the lack of muscle tone and narrowing of the airway, 
limiting air flow on inspiration during sleep[11] . The primary symptoms are daytime 
sleepiness and excessive fatigue. UARS has the same physical manifestations as OSA; 
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the difference is that people who have upper airway resistance rarely have apnea [12]. 
People with UARS have hypopnea which is the inability to take an effective breath 
while sleeping. The hypopnea leads to an increased work of breathing and therefore  
leads to fatigue and sleepiness[13]. 
 Snoring is a common condition that can affect anyone, conservatively 20-57% of 
the population[14]. It usually occurs more in men and people who are overweight.[15].  
Snoring occurs when the flow of air through the mouth and nose is physically 
obstructed[15].  Air flow can be obstructed by many factors: obstructed nasal airways, 
poor muscle tone in the throat and tongue , bulky throat tissue due to obesity, and long 
soft palate and/or uvula[15]. 
 
 
1.3 Diagnosis of Sleep Disorders 
 There are a wide range of health care professionals who can diagnose SDB. Often it 
is the family physician who notes some of the indicators for sleep apnea and they may 
then refer patients to a sleep lab for a sleep study. Pulmonologists, who specialize in 
breathing and lungs, may also diagnose sleep apnea. Sleep physicians who specialize in 
sleep medicine usually operate sleep labs that perform polysomnography. Dentists may 
be familiar with oral and craniofacial physical predictors of SDB. 
 Sleep apnea is usually diagnosed by a polysomnogram (PSG). This is an overnight 
sleep study done in a sleep lab. A PSG is a comprehensive recording of the 
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biophysiological changes that occur during sleep. Some of the functions that PSG 
monitors are  rapid eye movements, heart rhythm, respiratory effort, and oxygen 
saturation[16]. At the present time a PSG is required by insurance companies for a 
patient to be considered for any type of reimbursement for treatment of sleep apnea. 
There are take home-sleep studies (HST) like pulse oximetry that can be used. A pulse 
oximeter is a device that reads the oxygen saturation from the hemoglobin in the blood, 
records hours of sleep and monitors the heart rate [17]. The latest HST’s are small and 
look like watches that go on your wrist while you sleep at night. Research is being done 
to determine if the take HST’s are accurate enough to use more regularly to make the 
diagnosis process more convenient for the patient and acceptable to insurance 
companies[18]. Studies, as recent as 2013, have shown promise using pulse oximetry in 
children and surgical patient’s to diagnose SDB [19, 20]. PSG’s tend to be more 
expensive and inconvenient for the patient. Dmochowski et.al is doing studies to try and 
predict the apnea-hypopnea index (AHI) from an overnight pulse oximeter reading[18].  
Four main indicators are evaluated to determine if a person has sleep apnea. The first is 
the AHI, which refers to the number of apneic (cessation of breathing for10 seconds or 
more) and/or hypopneic (rapid shallow breathing) events a person has in an hour.  Mild 
sleep apnea is considered ≥ 5 but < 15 events/hr.; moderate sleep apnea is ≥ 15 but < 30 
events/hr. and severe sleep apnea is ≥ 30 events /hr.[16]. Depending on the type of sleep 
study done, the results may come in the form of an oxygen desaturation index (ODI) or 
respiratory disturbance index (RDI) which includes the patient’s respiratory effort 
related arousals (RERA) as well as the AHI.  The RDI’s tend to be higher because the 
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inclusion of the RERA’s.  These types of results usually accompany more extensive 
sleep studies like the PSG[18].The second indicator to predict sleep apnea is the lowest 
oxygen saturation score. This indicates how low or deprived of oxygen the patient was 
during the night. This number should be as close to 90% as possible so that the body is 
properly oxygenated for adequate body functions[9]. The third indicator to predict sleep 
apnea is the percent of time the patient’s oxygen saturation is below 90% (T90). Not 
only is it important to know how low a person desaturates (oxygenation falls below 
90%) but how long they stay there [21]. The brain cells can only be without oxygen for 4 
minutes before some type of permanent damage or death occurs [22]. The fourth 
indicator to predict sleep apnea is the mean average of oxygen the person maintained 
throughout the night. The mean average can vary according to altitude. For example the 
mean average is different between Texas and Colorado because Colorado is at a higher 
altitude. According to Goldberg et. al, arterial hemoglobin oxygen saturation decreases 
at an altitude ˃1,500m, therefore the mean oxygen average will be lower at higher 
altitudes [23]. This is the information a health care professional evaluates to help predict 
the presence of sleep apnea. 
 There are other instruments and techniques that can be used to predict if a patient 
has sleep apnea. Questionnaires can be used like the Stop-bang questionnaire or the 
Epworth Sleepiness Scale [24, 25] The Epworth scale has been translated into multiple 
languages and is used world-wide to assess patient sleepiness. These instruments ask 
questions that describe classic indicators of sleep apnea. Another technique is measuring 
the size of the patient’s neck. The adjusted neck circumference (ANC) is the neck 
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circumference of the patient in centimeters, and adding 4cm for hypertension, 3cm for 
snoring, and 3 cm if the patient was noted to gasp or choke at night. Once these items are 
added together a chart is provided to check the probability of the patient having sleep 
apnea (appendix 2). A person with an ANC of48cm has a good probability of having 
obstructive sleep apnea [26]. 
 
 
1.4 Treatment of Sleep Disorders 
 The gold standard non-surgical treatment for sleep disordered breathing is the use of 
a continuous positive airway pressure (CPAP) machine[10]. To use CPAP some type of 
mask and head gear is fitted to the face and the mask is attached to the machine by a 
hose. There are several different types of masks: full face mask, nasal mask, and nasal 
pillows that a patient can choose to wear. Once the mask is on securely the machine is 
turned on and a pre-set amount of pressurized air is delivered into the mouth and/or nose 
to hold open the airway to decrease the amount of AHI events throughout the night (see 
appendix 3). For patients with severe sleep apnea, a Bi-level positive pressure (Bi-PAP) 
machine can be used. Bi-PAP is similar to CPAP except it has inspiratory and expiratory 
pressures set. CPAP just supplies pressure on inhalation.  Studies on CPAP and Bi-PAP 
use have shown that compliance for these machines are often less than optimal [27].  
This is because these machines require daily use and maintenance, they are a significant 
intrusion in the bedroom environment and they can also affect quality of life [9, 28]. 
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 Other non-surgical options are therapeutic devices such as aOA’s (see appendix 4). 
Examples of aOA’s are the mandibular advancement and tongue retaining devices. The 
tongue retaining device is a custom appliance made of soft pliable material that retains 
the tongue by suction. This device is designed for edentulous patients to provide patency 
(opening) of the airway and promoting breathing through the nose. The mechanism of a 
mandibular advancement device (MAD) or aOA is to protrude the mandible enough to 
relieve the upper airway obstruction (tongue) which will lead to a patent airway for 
optimal gas exchange ( see appendix 5). A recent study showed that the aOA  or MAD is 
a preferred patient choice for treatment compared to CPAP for treating 
OSA[29].Overall,  CPAP is  more effective for severe OSA, but compliance with the 
aOA seems to be greater for mild to moderate OSA[28-30]. 
 There are some surgeries that can be performed to treat sleep apnea, such as the 
uvulopalatopharyngoplasty (UPPP) or nasal reconstruction [10]. There is insignificant 
data on the lasting effects of this surgery[10]. The goal of nasal reconstruction is to 
improve the patency of the nasal passages through surgery. Pharmacological treatments 
can target residual sleepiness with stimulants, like Provigil (modafinil) and Nuvigil 
(armodafinil). These drugs are understood to elevate the hypothalamic histamine levels 
which are assumed to be a “wakefulness promoting agent”[10]. 
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1.5 Comorbidities of Sleep Disorders 
  Sleep disorders are akin to the “silent killer”, heart disease, in that they frequently 
go undiagnosed. The symptoms are ignored and can contribute to other health-related 
disorders. Comorbidities caused by sleep disorders can manifest themselves as 
independent diseases delaying proper diagnosis [31].Conditions such as drug-resistant 
hypertension, obesity, myocardial infarction, congestive heart failure and atrial 
fibrillation (AF) are all comorbidities of sleep disorders [32, 33]. AF is a cardiac 
arrhythmia whose incidence increases with age [33]. The relationship between SDB and 
arrhythmias was proposed decades ago, but only recently has OSA been correlated with 
AF [32]. It is predicted that by 2050, more than 10 million Americans will have AF [32]. 
The known risk factors for AF are age, male gender, smoking , obesity, hypertension, 
diabetes , myocardial infarction, congestive heart failure, cardiac surgery, and 
obstructive sleep apnea [32]. People with SDB may be predisposed to arrhythmias 
because of alterations in sympathetic and parasympathetic nervous system due to the 
recurrent hypoxia, acidosis, apneas, and arousals caused by their condition [4]. Research 
performed by Mehra et al. demonstrated that patients with SDB are four times more 
likely to have cardiac arrhythmias. Due to theses comorbidities, OSA has had a 
substantial economic impact on society. The potential costs attributed to OSA include 
diagnosis, treatment, decrease in quality of life, and an increase of motor vehicle 
accidents[16].  
 
 
 10 
1.6 Economical Effects of OSA on Motor Vehicle Accidents 
 According to Kapur, obstructive sleep apnea related motor vehicle accidents cost 
taxpayers $15.9 billion in the year 2000 [16]. Congress unanimously passed the bill 
HR3095 on October 4, 2013, which was signed by President Obama on Oct.15,2013, 
regarding rulemaking instead of guidance dealing with OSA and commercial truck 
drivers [34, 35]. The bill states “The Secretary of Transportation may implement or 
enforce a requirement providing for the screening, testing, or treatment (including 
consideration of all possible treatment alternatives) of individuals operating commercial 
motor vehicles for sleep disorders only if the requirement is adopted pursuant to a 
rulemaking proceeding” [36]. The Federal Motor Carrier Safety Administration 
(FMSCA) is required to perform more detailed medical and physical exams for their 
drivers to be qualified to drive. The compliance date for the new regulation was January 
20, 2014 [37]. According to a study done by the American Association of Justice, big 
trucks make up less than 4% of all passenger vehicles, but are involved in 12% of all 
vehicle fatalities in which over 4000 people are killed each year [37]. Driver fatigue 
and/or health-related issues contributed to 15% of  the those fatalities [37].   
The Department of Transportation (DOT) data states that 28% of commercial 
drivers suffer from sleep apnea [37]. As of May 21, 2014 the only way to become 
medically certified to hold a commercial driver’s license (CDL) is to be examined by a 
medical examiner registered by the National Registry of Certified Medical Examiners 
(NRCME) [38]. The FMCSA estimates they will need 40,000 medical examiners 
nationally to be certified to meet the annual needs of over 4.6 million drivers [38]. The 
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old standard of performing medical exams to check for sleep disorders by the DOT was 
to provide questionnaires and use a body mass index (BMI) of 35 as a cut off for 
denying a license. Having a BMI of ≥ 35 is a risk factor for sleep apnea, and drivers 
falling in this category are required to have a sleep study. The national average cost of a 
polysomnogram (PSG) in 2014 is $2,625, which could be financially out of reach for 
truckers without insurance [37]. Another concern is the currently recommended method 
of treatment. CPAP machines are the recommended treatment but compliance is less 
than desirable [28, 39]. To hold a CDL, the driver must be compliant with their 
treatment and provide proof at their physical and medical exam. According to the 
American Academy for Dental Sleep Medicine (AADSM) aOA’s should be a 
recommended treatment for people with mild or moderate sleep apnea [40]. At this time 
the DOT has not approved the use of an OA as a viable treatment for CDL drivers due to 
the lack of compliance studies performed on them [41]. Although several studies have 
been done on compliance and systematic effects using CPAP [4, 27, 31, 39, 42], not 
enough definitive studies have been performed using aOA’s. 
 
 
1.7 Objective and Limitations of the Study  
1.7.1Objective 
This survey study was designed to assess the types of treatments sought by a cohort 
of sleep disordered breathing sufferers by reviewing patient’s attitudes and preferences 
toward different treatment modalities. This study will analyze how the patients acquired 
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their information on sleep disorders, pre and post symptoms, and treatment preferences 
as well as effects of sleep disorders on their quality of life. The survey explores the use 
of CPAP machines, Bi-PAP machines, aOA and any other treatment modalities used to 
treat patients with OSA and other sleep disorders. The patient population was people 
who have previously been diagnosed with some type of sleep disorder. This was a cross-
sectional study that used a cohort of patients from a single sleep treatment facility 
specializing in aOA treatment for SDB. All patients had previously been prescribed 
CPAP as treatment.  The survey included questions on how the subjects acquired their 
information on sleep disorders, how long they had a sleep disorder, where and who they 
sought for treatment of their disorder as well as a quality of life survey. 
 
 
 1.7.2 Limitations 
 Only one facility was used in this study because the other two facilities that were 
approached did not have patient permission to access their patient files for research. 
Obtaining email addresses from patient records dating back to the late 1990’s provided 
296 viable email addresses.  In addition to these email surveys 600 paper surveys were 
mailed out to patients. Because of the technical nature of some of the treatment 
procedures some subjects may not have known the correct name of the procedure that 
was performed and may have incorrectly answered certain questions. Some subjects may 
not answer all questions or not answer them completely and honestly. 
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CHAPTER II 
METHODS 
 
 CPAP is the gold standard for the treatment of OSA. However, recent studies [28-
30] have shown that oral appliances likewise can be highly effective. Yet, much less is 
known about patterns of patient use and patient preferences regarding oral appliance use. 
The purpose of this study was to investigate these patterns and preferences in a group of 
oral appliance users. 
 The Institute of Medicine estimates that 50 to 70 million adult Americans have 
some type of chronic sleep disorder that contributes to poor health [3]. Over the past 20 
years the percentage of men and women sleeping less than 6 hours per night has 
increased significantly [3]. Like the “silent killer” heart disease, OSA can go 
undiagnosed because the symptoms may contribute to other health related issues. Due to 
the loss of billions of tax dollars caused by OSA related motor vehicle accidents, 
Congress unanimously passed bill HR3095 on October 4, 2013. This bill was signed by 
President Obama on October 15, 2013,  regarding rulemaking instead of guidance 
dealing with OSA and commercial truck drivers[34, 35].  A study showed that big trucks 
make up less than 4% of all passenger vehicles, but are involved in 12% of all vehicle 
fatalities in which over 4000 people are killed each year[37].  The Department of 
Transportation (DOT) data states that 28% of commercial drivers suffer from sleep 
apnea[37]. 
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 According to American Academy for Dental Sleep Medicine(AADSM) oral 
appliances should be the first line of treatment for people with mild or moderate sleep 
apnea[40].  Severity of apnea is defined by AHI, which refers to the number of apneic 
(cessation of breathing for10 seconds or more) and/or hypopneic (rapid shallow 
breathing) events a person has in an hour.  Mild sleep apnea is considered ≥ 5 but  < 15 
events/hr.; moderate sleep apnea is ≥ 15 but <30 events/hr. and severe sleep apnea is ≥ 
30 events /hr.[16]. Treatment is considered successful when the apnea-hypopnea index 
(AHI) is < 5 or shows substantial reduction, defined as reduction in the index of at least 
50% from the baseline value [43]. 
 Studies done comparing OA’s and CPAP have shown no significant differences in 
treating the symptoms of mild and moderate sleep apnea[43-45].  Li et.al performed a 
meta-analysis of 14 trials that were acquired from MEDLINE, PubMed, EMBASE, and 
Central Register of Controlled trials.  The results demonstrated that the effects on 
Epworth Sleepiness Scale score, health-related quality of life, cognitive performance, 
and blood pressure of OAs and CPAP were all similar[44]. While studies have examined 
patient preferences and patterns for CPAP [46-48], less is known regarding oral 
appliances. Even though most studies prove that CPAP is more effective treating OSA, 
the patient population tends to choose OA’s for long term treatment of their symptoms 
[44, 49]. However, the reasons for this preference have not been systematically explored. 
Likewise, little is known about patient’s attitudes and preferences regarding OA’s. 
Growing  research on sleep disorders and the physiopathology of OSA has demonstrated  
dentistry playing an important role through the use of OA’s in increasing the lifespan of 
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individuals with OSA [50]. The etiology of this condition appears to be a combination of 
craniofacial abnormalities and neuromuscular factors that lead to the collapsibility of the 
upper airways [50]. The ability to titrate the MAD or aOA’s has proven effective in 
decreasing the AHI, increasing oxyhemoglobin saturation (SaO2) during sleep, reducing 
blood pressure, and improving heart rate variability [50, 51]. 
There have been several studies performed on the compliance and preferences of 
CPAP users [27, 39, 44, 52]. This study will address the patterns of patient use and 
preferences of oral appliance users. We would like to know what the subject’s 
preferential treatment modality is in regards to ease of travel, emotional and societal 
effects as well as interference with quality of life.   
 
 
2.1 Subjects 
 The inclusion criteria for the participants are: 1. previously have had a sleep study 
and were diagnosed with some type of sleep disordered breathing condition, 2. offered 
CPAP for initial treatment; 3. subjects are seeking treatment at a dental facility that only 
provides oral appliances for treatment of SDB. Subjects initially were to be chosen from 
3 dental practices that only supplied aOA for treatment of SDB. Data was only complied 
from one dental office due to the fact that they had previously had their patients sign 
consent forms for future study and research and the others had not.  
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2.2 Description of the Survey Instrument  
  A survey was developed to analyze patient knowledge of sleep disorders and 
treatments. Questions were asked about symptoms, treatment modalities, and the effect 
of the treatments on their quality of life. The Calgary Sleep apnea quality of life index 
short form section I was used as part of the survey to analyze quality of life.  The 
Calgary Sleep Apnea Quality of Life Index (SAQLI) has been designed as a disease 
specific quality of life( QOL) measure that will be sensitive in detecting change in the 
QOL of people with sleep apnea who have undergone some type of treatment 
intervention[53]. Other questions in the survey consisted of patient demographics: age, 
sex, race, and occupation. There are questions that asked what type of  SDB they sought 
treatment for , what type of SDB they are currently being treated for, who have they seen 
for treatment and who are they currently seeing for treatment. The last groups of 
questions are a comparison of the two treatment modalities CPAP and OA’s. They 
compare the difficulty of traveling, the level of comfort, how rested they feel in the 
morning, and the interference of quality of life after using CPAP or OA for treatment. 
 
 
2.2.1 Pilot Testing Procedures 
 Before testing was done, the survey was approved by the Institutional Review Board 
(IRB) Texas A&M University Baylor College of Dentistry. The survey was given to 10 
current aOA users.  The survey was sent by mail and email. A link to Kwik Survey with 
the survey questions was sent to the focus groups available email. Each individual was 
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given these instructions: 1) record the time it takes to complete the survey, 2) provide 
information on the clarity of the questions, 3) and return the survey in one week. Once 
the surveys were returned the data was analyzed and changes were made to improve the 
survey instrument based on subjects’ responses.  Some of the changes that were made 
after the pilot survey was done were the addition of current symptoms to the SAQLI. 
The survey originally asked for symptoms before treatment only.  Another change that 
was made after the pilot survey was simplifying language in some of the questions. This 
simplification made the questions less confusing while getting the information that was 
needed.    
 The survey instrument consisted of 43 questions. The questions contain multiple 
choice, yes/no, and Likert scale questions. The Likert scale rates a subject from 1 to 7, 
with 1 being the least and 7 being the most. The survey took approximately 20 minutes 
to complete. The questions were grouped by topics. The topics include demographics, 
knowledge, and practices. The demographic questions were intended to acquire pertinent 
data on their race, age, sex, and occupation. There were questions about knowledge and 
symptoms of sleep disorders, which treatments were used and are currently being used to 
manage subjects’ sleep disorders, and  to determine the effect if any the treatment 
modalities  had on their quality of life (SAQLI).  
 The survey was mailed and emailed to 600 and 296 individuals respectively who 
had been diagnosed with a sleep disorder within the past 15 years.  A systematic random 
sampling formula was created to choose from the available files from a dental office that 
only provide aOA to their patients.  A mailing list was assembled from those charts 
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randomly pulled. An email list was also compiled from what was available. There was a 
wide range of years from 1998 to the present so email addresses were not readily 
available in some of the charts that were chosen. Each participant received an informed 
consent form, cover letter, survey (Appendix 1), and a stamped return envelope 
addressed to the researcher at Texas A&M University Baylor College of Dentistry.   
 
 
 2.2.2 Statistical Analysis  
This survey was a retrospective cross-sectional study which gathered information 
from participants’ past and present treatment history. SPSS software was used to analyze 
the data.  The data gathered was ordinal and was analyzed by non-parametric 
procedures. For the SAQLI questions the Wilcoxon Signed Rank test was used.  The 
Mann-Whitney U-test was the non-parametric test used for the comparison questions 
about CPAP and OA’s to analyze the data at a 95% confidence level. The information 
was gathered from subject’s files only when they had previously signed a consent form.  
 
 
2.3 Limitations 
  Obtaining email addresses from patient records in the late 1990’s was difficult due 
to the lack of home computer usage at this time. It also took quite some time to acquire 
enough addresses for the calculated sample because of the lengthy period of recall.  
Having access to only one facility to acquire patient data, instead of the intended 3, 
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limited our ultimate sample sizes. Because of the technical nature of some procedures, 
some subjects did not know how to answer some of the questions.  
 
 
2.4 Results 
 There were 600 written survey’s mailed. Out of the 600 there were 58 viable 
responses and 61 packages returned to sender. There were 296 online surveys sent out 5 
days after the original mailing with email addresses obtained from the original 600 
subjects. 26 responses were received from the online survey with only 9 duplicates from 
the 58 written responses received. Another 263 online surveys were sent out with 21 
responses and 10 duplicates from the previous online survey. Therefore out of 896 
written and online surveys 86 viable responses were obtained. This comes to a 10% 
response rate and not the desired 25% response rate. 
 The ages ranged from 40-84 with a mean age of 62.15 and a mode age of 64. The 
subjects were 70.9% male and 29.1% female. The ethnicity of the group was 93% 
White, 4.7% Black, and 2.3% Asian. The occupations for the subjects were quite diverse 
from homemakers to bankers and physicians. Subjects acquired 94.3% of their 
knowledge about sleep disorders from various sources including primary care 
physicians, dentists, sleep doctors, the internet, family, and friends. Subjects were asked 
how long they have had a sleep disorder resulting in the following frequencies: 0-2 
years=5.8%, 3-5 years=15.1%, 6 years or more=76.7% and 2.3% went unanswered. 
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The subjects were asked several questions about their approach to treatment: What 
type of SDB were you seeking treatment for? What SDB are you currently being treated 
for? Who have you seen to treat your SDB, and who do you currently see for your SDB?  
The results (Table 1) show that the majority of the subjects initially sought treatment for 
snoring (40.7%) and a combination of snoring and OSA (24.4%). Currently,   37.2% are 
being treated for combination snoring and OSA, 31.4% treated for OSA, and only 18.6% 
being treated for snoring. The subjects have primarily seen sleep physician or a dentist 
(27.9%) for initial treatment. Some of the subjects sought no treatment (3.5%).  For 
current treatment the subjects see dentists (37.2%), a combination of dentists and sleep 
physician (20.9%), and 10.5% are currently not seeking treatment. 
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Table 1: Approach to treatment 
 
 
  
 Next are the results of the  SAQLI which used a likert scale of 1-7, where 1 is the 
least and 7 is the most, to answer questions  that reflect patient symptoms before and 
after treatment. In Fig. 1 the results show significant improvement in all QOL measures 
after treatment. For example in   Fig. 1A (How much have you had to push yourself to 
stay alert during a typical day?), before treatment the majority of the subjects answered 
moderate to large amount of energy to stay alert (24.4%) during the day. After treatment 
the majority of the subjects stated that it took a small amount of energy to stay alert 
 22 
(37.2%) during the day.  Other questions (Fig. 1, B-F) showed improvements in energy, 
tiredness, sociability, and mood. 
 
 
FIG. 1-SAQLI ENERGY LEVELS 
 
Before symptoms  
Current symptoms 
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FIG. 2-SAQLI DIFFICULTIES AND PROBLEMS 
 
Before symptoms 
Current symptoms 
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  The next group of QOL questions relates to the subject’s difficulties and problems 
that arise from lack of sleep and energy that affects their mental and emotional status.  
The results of these questions are in Figs. 2 and 3.   Even though there is significant 
improvement in all of the symptoms after treatment, some improvements were quite 
large. For example, in Fig. 2B (How much difficulties have you had fighting to staying 
awake?),  subject’s responded 24.4% moderate to large amount of energy to stay awake 
before treatment and 43% small amount after treatment. Fig.2C (How much of a 
problem has it been to be told that your snoring is irritating?), subject’s response was 
26.7% large amount of irritation before treatment and 47.7% a small amount of irritation 
after treatment. There were also large changes in Fig. 3C&D. Fig.3C( How much of a 
problem have you had with fatigue?), subject’s response was 20.9% moderate to large 
amount of problem with fatigue before treatment and 38.4% was a small amount of 
problem with fatigue after treatment. Fig.3D (How much of a problem have you had 
waking up feeling unrefreshed?), subject’s response was 22.1% did not feel refreshed in 
the morning before treatment and 41.9% had a small amount of problem feeling 
refreshed after treatment.  
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FIG. 3-SAQLI LEVELS OF COMFORT 
 
Before symptoms 
Current symptom 
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 Using a likert scale of 1-7, there are questions which compare CPAP to aOA’s 
under the same conditions.  The results of these questions also show a significant change 
in before and after treatment. But a large change was reflected in Fig.4 A & D. Fig. 4A 
(How much difficulty do they have traveling using CPAP or OA?), the subjects response 
was 3.5% had difficulty traveling with CPAP and 2.3 % had no problem. For this same 
question 2.3% of the subject’s had problems traveling with OA’s and 62.8% had no 
problems.  In Fig. 4D (Has treating your SDB with CPAP or OA’s interfered with your 
quality of life?), subjects response was 8.1% stated that the use of CPAP interfered with 
their quality of life and 3.5% stated that it did not. The results for OA’s were 4.7% stated 
that it interfered with their quality of life and 50% stated that they did not. This study 
shows the subjects believe using oral appliances benefits them better while traveling and 
creates less interference in their quality of life. 
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FIG. 4-COMPARISON GRAPHS 
 
 
 
CPAP 
OA 
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CHAPTER III 
DISCUSSION AND CONCLUSION 
 
 3.1 Discussion 
 This survey is one of the first to address general knowledge of sleep disorders by 
apnea sufferers. The survey reviewed how the subjects acquired their knowledge of sleep 
disorders, their pre and post symptoms after treatment, and if their choice of treatment 
interfered with their QOL.  The subjects acquired 94.3% of their knowledge about sleep 
disorders from various sources including primary care physicians, dentists, sleep doctors, 
the internet, family and friends. In 2006 the Institute of Medicine Committee of Sleep 
Medicine and Research commissioned a book on improving awareness, diagnosis, and 
treatment of sleep disorders[54]. The United States government has made attempts in 
public awareness of the health issues caused by sleep disorders by initiation of “Sleep: a 
health imperative” to educate the nation on the importance of adequate sleep [3].  There 
also was an attempt by Firestone in exploring the knowledge and attitudes of taxi drivers 
in Wellington New Zealand in regards to OSA[55]. Firestone concluded that the taxi 
drivers need systematic education to help them understand sleep deficiency and OSA’s 
effects on their driving skills and safety [55].  
 A few of the symptoms that accompany sleep disorders are fatigue, snoring, gasping 
for breath, daytime sleepiness, and depression[25, 31]. Research is being done to provide 
sleep disorder sufferers with treatments they can use to manage their symptoms so they 
can live a relatively normal life. There have been many studies done on CPAP, as it has 
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been the treatment of choice since the discovery of sleep disorders [16, 27, 52]. Recent 
studies suggest that OA are a viable treatment choice for mild or moderate sleep apnea 
[16, 27, 52, 56]. The fact that this data has recently been published has not given patients 
much time to utilize OA therapy. This study and a few others have begun to compare the 
use of CPAP and OA as treatments, to analyze effectiveness and patient preference [43, 
44, 57]. Our study shows that all symptoms had improved with treatment.  There were 
two main treatment modalities that were chosen: CPAP and OA’s. In our survey, 11.6% 
of patients chose to continue CPAP following initial treatment while 80.2% opted for 
OA’s. The comparison questions between the treatment modalities CPAP and OA’s 
analyzed the patient’s difficulty traveling, level of comfort, if they felt refreshed in the 
morning, and if the treatment affected their QOL. The results showed that of the 11.6% 
of CPAP users, 3.5% stated that it caused difficulty traveling. In the CPAP group, the 
feeling of most comfort is 2.3%, waking up feeling refreshed is 10.5%, and 8.1% feel 
that it has affected their QOL. Of the 80.2% of OA users, 2.3% have difficulty traveling, 
18.6% had the most feeling comfort, waking up feeling refreshed 19.8%, and 4.7% say it 
affects their QOL. Overall the majority of the subjects chose aOA’s as their treatment of 
choice. Because the research of using aOA’s for a consistent treatment for SDB is still in 
its early stages, studies like this one are needed to get closer to giving SDB sufferer’s 
treatment choices. If the SDB sufferers can treat their symptoms with their preferred 
treatment then this will provide them with the QOL they want. 
  Quality of life addresses how SDB affects the physical, emotional, and social 
aspects of a person’s life[47]. The short from of the Calgary Sleep Apnea Quality of Life 
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index was used to acquire the data for this study. This study demonstrates that any form 
of treatment improves quality of life. SDB is a progressive disease and left untreated the 
mortality rate for severe OSA is 30% at 15 years [58]. Education is the key to early 
detection of SDB.  We should not only educate the general public, but also the health 
care professionals. 
 This study showed that dentists lead in current treatment of SDB at 37.2%; therefore 
it is only natural for dentistry to take an educational lead.  A 2012 survey was given to 
58 US dental schools on the amount of somnology hours in their predoctoral curriculum. 
They discovered that even though 75.5% of the schools participated in the survey, the 
schools averaged 3.92 educational hours on SDB[59].   There are 250 qualified treatment 
centers nationwide that only treat approximately 5% of OSA sufferers, this alone makes 
it imperative that dental education fill the void and train professionals for the future[60]. 
The UTHSC College of Dentistry is adding OSA and snoring to the predoctoral dental 
curriculum. UTHSC believes the dental profession is not doing enough to help diagnose 
this underdiagnosed disease[60]. Sleep disorders affect 50-70 million Americans 
therefore UTHSC suggests that educating students about OSA and early engagement in 
treatment can help dental professional have a fighting chance with this steadily rising 
disease[60]. Educating dentists and hygienists in the art of early detection of SDB can 
help the general public recognize and seek treatment for sleep disorders. 
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3.2 Conclusion 
  This study surveyed quality of life in a group of sleep disorder sufferers, who 
primarily chose OA as their preferred treatment. While CPAP is effective for severe 
OSA, recent studies have indicated that OA is effective for mild and moderate OSA [28-
30]. Yet we know relatively little about knowledge and preferences in this population. 
This survey revealed that 59.3% primarily obtained their knowledge about sleep 
disorders from their sleep physician and dentist. After the survey 11.6% of the subjects 
chose to continue to use CPAP and 80.2% chose to use OA’s.   The survey showed that 
76.7% of the survey subjects suffered with SDB for 6years or more. Having SDB led to 
decreased physical, emotional, and social aspects of their lives which than led to poor 
quality of life. The survey showed significant improvement in all aspects of quality of 
life after treatment.  By educating the community and health care professionals we can 
work together to help keep this progressive disease from getting out of hand. With this 
knowledge we can decrease OSA related fatalities that causes economic spending and 
improve the quality of life of apnea sufferers. In 2012 it was recorded by the National 
Center for Health Statistics that 61.6% of the population visited the dentist[61]. With 
questionnaires about SDB’s added to the health history forms and predicting techniques 
used by the dentists and hygienists during exams they can help identify patients at risk 
for OSA.  
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APPENDIX I 
SURVEY 
  
Directions: Please read each question carefully and select the answers that best fit your situation and 
fill in the blanks where a written answer is required. This survey has 43 questions and will take 
approximately 20 minutes to complete. Your answers will be completely confidential. Thank you for 
your participation. 
 
Sleep Apnea Quality of Life Index 
Please answer questions 1-14 in regards to your symptoms before and after you were treated. We 
would like to understand whether your sleep apnea and /or snoring has had an impact on your daily 
activities, emotions, social interactions, and about symptoms that may have resulted. 
Please Score the following Questions According to the Following: (fill in the circle) 
 
1=a very large     2= a large    3= a moderate to large    4= a moderate    5= a small to moderate     6= a 
small     7= no or none 
 
1. How much (amount) have you had to push yourself to remain alert during a typical day (e.g. work, 
school, childcare, housework)?   
 
 Symptoms before: a very large       a large      a moderate to large     a moderate    a small to moderate       a small       no/none 
 
 
 Current symptoms:   a very large   a large    a moderate to large      a moderate    a small to moderate       a small       no / none 
 
 
        2.  How much (amount of time) of your energy is used to accomplish your most important activity  
                                       (e.g. work, school, childcare, housework)?        
 Symptoms before:  a very large    a large       a moderate to large      a moderate    a small to moderate       a small       no /none 
 
 
 Current symptoms:  a very large   a large  a moderate to large    a moderate    a small to moderate         a small       no /none 
 
 
3. How much difficulty (amount) have you had finding the energy to do other activities (e.g. exercise,     
relaxing)? 
 
Symptoms before: a very large     a large     a moderate to large      a moderate    a small to moderate      a small            no/none 
 
 
Current symptoms:  a very large   a large    a moderate to large      a moderate    a small to moderate      a small       no /none 
 
 
        4. How much difficulty (amount) have you had fighting to stay awake?   
        
  Symptoms before: a very large   a large      a moderate to large      a moderate    a small to moderate        a small       no / none 
 
 
 Current symptoms:  a very large a large  a moderate to large      a moderate    a small to moderate         a small       no /none 
 
      5. How much of a problem has it been to be told that your snoring is irritating? 
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  Symptoms before : a very large   a large     a moderate to large      a moderate    a small to moderate        a small       no / none 
 
 
 Current symptoms: a very large    a large      a moderate to large    a moderate    a small to moderate     a small     no / none 
 
  
      6. How much of a problem have frequent conflicts or arguments been? 
 
Symptoms before:    a very large      a large       a moderate to large      a moderate    a small to moderate   a small       no / none 
 
 Current symptoms:  a very large    a large     a moderate to large    a moderate    a small to moderate    a small       no / none 
 
 
          7. How often (amount of time) have you looked for excuses for being tired? 
 
Symptoms before: a very large      a large     a moderate to large      a moderate    a small to moderate      a small       no / none 
 
 
Current symptoms:  a very large   a large   a moderate to large    a moderate    a small to moderate        a small       no / none 
 
 
           8. How often (amount of time) have you not wanted to do things with your family and /or friends? 
 
 Symptoms before: a very large  a large      a moderate to large      a moderate    a small to moderate          a small       no / none 
 
  
Current symptoms:  a very large   a large   a moderate to large      a moderate    a small to moderate       a small       no/ none 
 
            9. How often (amount of time) have you felt depressed, down, or hopeless? 
 
 Symptoms before:  a very large      a large       a moderate to large      a moderate   a small to moderate       a small     no / none 
 
 
Current symptoms:  a very large  a large  a moderate to large      a moderate    a small to moderate        a small       no / none 
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10. How often (amount of time) have you been impatient? 
 
    Symptoms before: a very large  a large     a moderate to large      a moderate    a small to moderate         a small       no/none 
   
 
    Current symptoms: a very large   a large   a moderate to large    a moderate   a small to moderate      a small     no / none 
 
 
11. How much of a problem has it been to cope with everyday issues?  
 
   Symptoms before: a very large  a large       a moderate to large      a moderate    a small to moderate      a small       no/ none 
 
 
   Current symptoms:  a very large a large     a moderate to large      a moderate    a small to moderate   a small     no / none 
 
 
12. How much of a problem have you had with decreased energy? 
 
   Symptoms before:  a very large    a large      a moderate to large    a moderate    a small to moderate       a small       no/ none 
 
 
     Current symptoms:  a very large   a large   a moderate to large   a moderate    a small to moderate    a small       no / none 
  
 
13. How much of a problem have you had with fatigue? 
 
    Symptoms before:  a very large     a large     a moderate to large      a moderate    a small to moderate    a small       no /none 
 
 
   Current symptoms:  a very large  a large   a moderate to large    a moderate    a small to moderate     a small       no /none 
  
 
14. How much of a problem   have you had waking up feeling unrefreshed? 
 
   Symptoms before: a very large    a large       a moderate to large      a moderate    a small to moderate     a small       no /none 
                            
 
 Current symptoms:  a very large   a large   a moderate to large   a moderate    a small to moderate    a small       no/none 
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15 Age_____________ 
16 Sex  (circle one)   M/ F  
17 To what ethnic group do you 
belong? 
a. White 
b. Black 
c. Asian 
d. Hispanic 
e. Other________________ 
18 What is your occupation? (fill in the 
blank) 
     ______________________________ 
19 How long have you had a sleep 
disordered breathing condition? 
a. 0-2 years 
b.     3-5 years 
c.    6 or more years 
 
20 What sleep disordered breathing 
condition did you seek treatment for 
initially? (choose all that apply) 
 
a. Snoring 
b. Obstructive sleep apnea 
c. Upper airway resistance syndrome 
d. Other__________________ 
 
21  What sleep disordered 
breathing condition are you being 
treated for? (choose all that apply) 
a. Snoring  
b. Obstructive sleep apnea 
c. Upper airway resistance syndrome 
d. Other________________ 
 
22 How did you get your information 
on sleep disorders? (choose all that 
apply) 
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a. Internet 
b. Family/friends 
c. Physician/dentist 
d. Library 
e. Newspaper/magazine 
f. Other________________ 
 
23 Who do you currently see for your 
sleep disordered breathing condition? 
(choose all that apply) 
a. Family physician 
b. Sleep physician  
c. Dentist 
d. No one 
e. Other____________ 
 
24 Who have you seen for your sleep 
disordered breathing condition? (choose 
all that apply) 
 
a. Family physician 
b. Sleep physician 
c. Dentist 
d. No one  
e. Other____________ 
 
 
25 Do you use any type of 
pharmacological treatment that helps 
you stay awake? (choose all that apply) 
 
a.  Provigil (Modafinil) 
b.  Nuvigil (Armodafinil ) 
c.  Ritalin (Methylphenidate) 
d.  Adderall (Amphetamine) 
e.  None 
f. Other________________ 
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26  Do you use any type of 
pharmacological treatment that helps 
you go to sleep?(choose all that apply) 
a. Ambien (Zolpidem) 
b. Lunesta (Eszopiclone) 
c. Sominex (Diphenhydramine) 
d. Melatonin (Synthetic hormone) 
e. None 
f. Other ___________ 
 
27 Have you used any of these 
treatments for your sleep disordered 
breathing condition? (choose all that 
apply) 
 
a. Uvulopalatopharyngoplasty(UPPP) 
surgery                     
b. Pillar implants 
c. Nasal reconstruction surgery 
d. Continuous Positive Airway 
Pressure     machine (CPAP)  
e. Bi-level Positive Airway Pressure 
machine (Bi-PAP) 
f. Mandibular surgery 
g. Distraction osteogenesis 
h. Oral appliances such as the 
Thornton Adjustable Positioner (TAP), 
SomnoDent or Elastic Mandibular 
Advancement Device (EMA) 
i. Other________________ 
28 What device do you currently use to 
manage your sleep disordered breathing 
condition?(choose all that apply) 
a. CPAP 
b. Bi-PAP 
c. TAP 
d. Herbst 
e. EMA 
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f.Other(describe)___________________
________________________________
________________________________ 
29 If you use CPAP/Bi-PAP, what type 
of attachment do you wear with your 
machine? (choose all that apply or not 
applicable) 
a. Face Mask 
b. Nasal pillows 
c. Nasal Mask 
d. Hybrid Mask 
e. Oral appliance 
f. Not applicable 
g. Other________ 
 
 
30 Do you wear your CPAP/Bi-PAP 
machine every night? Yes____ No____.  
If yes, how many hours per night? 
a. 0-4 
b. 5-7 
c. 8 or more  
d. Not applicable 
31 Have you had any of these 
complications while using a positive 
airway pressure machine like CPAP or 
Bi-PAP? (choose all that apply) 
 
a. Leakage 
b. Sinus problems 
c. Tear duct problems 
d. Dry mouth 
e. Excess fluid from tubing 
f. Excess air in stomach 
g. Breakdown of skin 
h. Claustrophobic feeling 
i. None 
j. Not applicable 
k. Other___________ 
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32 Does your sleep disorder restrict 
you from traveling? 
a. Yes 
b. No 
c. Not applicable 
33 If you answered yes to #32 and use 
a CPAP/Bi-PAP machine, how difficult 
is traveling? (on a scale from 1-7, with 1 
being the least difficult, 7 the most 
difficult, and N/A is not applicable). 
Circle one. 
     1    2    3    4    5     6     7     N/A 
 
34   On a scale from 1 -7 what is your 
amount of comfort using CPAP/Bi-PAP. 
(1 is the least comfortable, 7 the most 
comfortable and N/A is not applicable). 
Circle one. 
   1     2     3     4     5     6     7     N/A 
 
35 On a scale from 1-7, how refreshed 
or rested do you feel the next morning 
after using CPAP/Bi-PAP? (1 is the least 
rested 7 the most rested and N/A is not 
applicable). Circle one. 
 
 1     2     3     4     5     6     7     N/A 
  
36 Has treating your sleep disordered 
breathing condition with CPAP/Bi-PAP  
interfered with your quality of life? 
(Quality of life meaning that you have 
the strength and energy to accomplish 
the life tasks that you want in order to 
lead a fulfilling life) (1 is the least 
interference, 7 the most interference, and 
N/A is not applicable). Circle one. 
 
  1     2     3     4     5     6     7     N/A 
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37 Are you still using your CPAP/Bi-
PAP machine to manage your sleep 
disordered breathing condition? 
 
a. Yes 
b. No 
c. Not applicable 
38 Have you had any of these 
complications while using an oral 
appliance? (choose all that apply) 
 
a. Sore teeth 
b. Jaw pain/discomfort 
c. Excessive saliva 
d. Dry mouth 
e. Claustrophobic feeling 
f.  Not applicable 
g. Other__________ 
39 How difficult is traveling using an 
oral appliance? (on a scale from 1-7, 
with 1 being the least difficult, 7 the 
most difficult, and N/A is not 
applicable). Circle one 
    1    2    3    4    5    6    7    N/A 
  
40  On a scale from 1 -7 what is your 
amount of comfort using oral appliance. 
(1 is the least comfortable, 7 the most 
comfortable and N/A is not applicable). 
Circle one. 
 1   2     3     4     5     6     7     N/A 
 
41 On a scale from 1-7, how refreshed 
or rested do you feel the next morning 
after using oral appliance? (1 is the least 
rested 7 the most rested and N/A is not 
applicable). Circle one. 
 
1    2     3     4     5     6     7     N/A 
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42 Has treating your sleep disordered 
breathing condition with oral appliance 
interfered with your quality of life? 
(Quality of life meaning that you have 
the strength and energy to accomplish 
the life tasks that you want in order to 
lead a fulfilling life) (1 is the least 
interference, 7 the most interference, and 
N/A is not applicable). Circle one.  
1     2     3     4     5     6     7     N/A 
43 Are you still using your oral 
appliance to manage your sleep 
disordered breathing condition? 
a. Yes 
b. No 
c. Not applicable 
Comments:  
________________________________
________________________________ 
Thank You for your Participation!!
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APPENDIX II 
ADJUSTED NECK CIRCUMFERENCE 
  
  
                                                                                                        
Neck Circumference (In) _____ X 2.54 _______cm          Probability of Obstructive 
                                                                                                      Sleep Apnea 
 
                                                                                             ________Low 43*                                                                                                                                           
Add 4 cm for hypertension         _______cm                      ______Intermediate (43-48)      
Add 3 cm for snoring           _______cm                      _________High > 48 
Add 3 cm for gasping/choking   ________cm 
  Total                             ________cm 
 
 
 
 
 
 
 
 
 
 
 
*Note that if a patient’s neck size falls in the low category and they still have the fatigue 
symptoms it is likely that they may have Upper Airway Resistance Syndrome. 
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APPENDIX III 
CPAP MASK AND WORKING DESCRIPTIONS 
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APPENDIX IV 
SAMPLE OF TAP ORAL APPLIANCE 
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APPENDIX V 
MODE OF OPERATIONS OF aOA 
 
 
 
 
